Streetbeat News

Stock Prices

AI

Recent options trading trends for C3.ai (NYSE:AI) show a bearish sentiment among financial giants, with 62% of trades indicating bearish tendencies. The trading activity suggests a target price range of $22.5 to $35.0 for C3.ai. Notable options activity includes both bullish and bearish trades with varying expiration dates and strike prices. C3.ai, an enterprise AI company, is currently trading at $28.09, with a slight decrease of -1.02%. Analyst ratings from Piper Sandler, B of A Securities, and Canaccord Genuity offer mixed views, with target prices ranging from $20 to $33.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 6:16 pm

VALN

Valneva (NASDAQ:VALN) received mixed analyst ratings, with a recent shift towards a bullish outlook. The average 12-month price target is $23.75, marking a 31.94% increase from the previous target. Despite facing a significant revenue decline of -75.7% as of September 30, 2023, and challenges in revenue growth and ROE, Valneva's net margin and ROA outperform industry standards. The company's debt-to-equity ratio is higher than the industry average, indicating a reliance on borrowed funds.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 6:01 pm

AFRM

Affirm Holdings (NASDAQ:AFRM) has seen significant options trading activity, with a bearish sentiment prevailing among big-money investors. Benzinga's options scanner revealed 16 unusual trades, with a split sentiment of 18% bullish and 81% bearish. The focus is on a price band between $32.0 and $50.0. The trading volume and open interest suggest heightened activity in this range. AFRM's current market status shows a slight price decrease and an upcoming earnings announcement in 46 days.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 6:00 pm

FDX

LULU

NKE

NKTX

NVDA

TLT

Stocks slightly retreated in New York's morning session on Friday, with the S&P 500 nearing its best week of 2024 after a dovish Federal Reserve meeting. Nvidia Corp. rallied for the 11th week, while Bitcoin and gold saw declines. The iShares 20+ Year Treasury Bond ETF rose, and major indices showed mixed results. Notable stock movements included Nike's drop due to a revenue decline forecast, FedEx's rise after exceeding earnings expectations and announcing a buyback program, Lululemon's fall despite positive earnings, and Nkarta's decline after price target cuts.

Portfolio Pulse from Piero Cingari

March 22, 2024 | 5:55 pm

NKTX

Nkarta Inc (NASDAQ:NKTX) stock fell 29.4% to $9.17 after announcing the deprioritization of its NKX101 cancer drug program following a review of preliminary safety and response data. The company is redirecting resources to its lead pipeline program, NKX019, for autoimmune disease. Despite initial promising results, the aggregate CR/CRi rate for NKX101 in a clinical trial was lower than expected. Nkarta plans to focus on NKX019, with a study on lupus nephritis set to begin in the first half of 2024. As of December 31, 2023, Nkarta reported having sufficient funds to support operations into 2026.

Portfolio Pulse from Vandana Singh

March 22, 2024 | 5:49 pm

MS

Morgan Stanley (NYSE:MS) has seen a balanced mix of bullish and bearish options trading activity, with significant investors targeting a price range of $70.0 to $97.5 over the next three months. The trading volume and open interest for options indicate a keen investor interest. Morgan Stanley, a global investment bank with over $4 trillion in client assets, has its stock price slightly up at $93.47, with an RSI suggesting it may be approaching overbought territory. Analysts, including one from Oppenheimer, maintain an Outperform rating with a target price of $97.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 5:46 pm

LOW

High-rolling investors have shown a bearish sentiment on Lowe's Companies (NYSE:LOW) through recent options trades, as tracked by Benzinga. A total of 8 options trades were identified, with a sentiment of 100% bearish, focusing on a price band between $240.0 and $280.0. The trading activity includes one put and seven calls, with significant trade prices and varying open interest. Lowe's is a major home improvement retailer, and its stock price is slightly up by 0.02% at $261.05. Analysts have mixed opinions, with an average target price of $250.2, and ratings ranging from Buy to Hold.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 5:45 pm

BIIB

ESALF

ESALY

The European Medicines Agency (EMA) has postponed the Oral Explanation for Biogen Inc and Eisai Co Ltd's Alzheimer's drug, Lecanemab, due to procedural issues. This delay affects the drug's review process, initially expected to conclude by June 30, 2024. The postponement follows a recent court ruling impacting EMA's policy on managing conflicts of interest among its Scientific Advisory Groups. Despite the delay, an approval is still anticipated in the second half of 2024. BIIB shares dropped 1.10% following the news.

Portfolio Pulse from Vandana Singh

March 22, 2024 | 5:44 pm

ASO

Truist Securities analyst Joseph Civello reiterated a Buy rating on Academy Sports and Outdoors Inc (NASDAQ:ASO) but lowered the price target from $77 to $75, citing a post-holiday slump and a conservative outlook under new leadership. The company's Q4 FY23 sales and adjusted EPS missed analyst estimates, with sales growing 2.8% year-on-year to $1.794 billion and adjusted EPS at $2.21. The FY comp guidance of down (4%) to +1% reflects the new CEO/CFO's conservative outlook, despite positive signs in the Outdoor category and potential for gross margin improvement.

Portfolio Pulse from Shivani Kumaresan

March 22, 2024 | 5:41 pm

ERJ

Embraer's stock price increased following Goldman Sachs' decision to maintain a Buy rating and raise its price target from $21 to $35.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 5:37 pm